The Novo Nordisk headquarters in Bagsvaerd, Denmark. Photo: Bloomberg
Bloomberg
Novo Nordisk says it is suing Hims & Hers Health for making knock-off versions of its obesity medicines, even as Hims scrapped plans to sell a copycat version of the Wegovy pill.
Hims is breaching the US patent on semaglutide, the active ingredient in Novo’s blockbuster obesity treatments, Novo argued.
source